Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Common Equity: 2013-2025

Historic Common Equity for MediWound (MDWD) over the last 2 years, with Jun 2025 value amounting to $20.1 million.

  • MediWound's Common Equity rose 12.59% to $20.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $20.1 million, marking a year-over-year increase of 12.59%. This contributed to the annual value of $31.2 million for FY2024, which is 1.40% down from last year.
  • Per MediWound's latest filing, its Common Equity stood at $20.1 million for Q2 2025, which was down 35.42% from $31.2 million recorded in Q4 2024.
  • MediWound's 5-year Common Equity high stood at $34.9 million for Q2 2023, and its period low was -$4.6 million during Q4 2021.
  • Over the past 3 years, MediWound's median Common Equity value was $31.2 million (recorded in 2024), while the average stood at $27.1 million.
  • Per our database at Business Quant, MediWound's Common Equity plummeted by 205.52% in 2022 and then surged by 1,662.82% in 2023.
  • Over the past 5 years, MediWound's Common Equity (Quarterly) stood at -$4.6 million in 2021, then skyrocketed by 338.19% to $10.9 million in 2022, then spiked by 189.49% to $31.6 million in 2023, then declined by 1.40% to $31.2 million in 2024, then increased by 12.59% to $20.1 million in 2025.
  • Its Common Equity stands at $20.1 million for Q2 2025, versus $31.2 million for Q4 2024 and $17.9 million for Q2 2024.